Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.77 |
| ▸ | MAPT | P10636 | 7/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.77 |
| ▸ | RXRA | P19793 | 5/20 | 0.77 |
| ▸ | RARA | P10276 | 4/20 | 0.77 |
| ▸ | RARB | P10826 | 4/20 | 0.77 |
| ▸ | RARG | P13631 | 4/20 | 0.77 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.77 |
| ▸ | APP | P05067 | 4/20 | 0.77 |
| ▸ | SNCA | P37840 | 4/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.77 |
| ▸ | RXRB | P28702 | 2/20 | 0.77 |
| ▸ | RXRG | P48443 | 2/20 | 0.77 |
| ▸ | RORC | P51449 | 2/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.77 |
| ▸ | HTR2B | P41595 | 2/20 | 0.77 |
| ▸ | BLM | P54132 | 2/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.77 |
| ▸ | DRD3 | P35462 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4821667 | 1.00 | ALDH1A1 (0.77) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL17052744 | 1.00 | ALDH1A1 (0.77) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL7162641 | 0.95 | ALDH1A1 (0.85) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL7175145 | 0.95 | ALDH1A1 (0.85) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL10623339 | 0.94 | ALDH1A1 (0.88) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL10623334 | 0.94 | ALDH1A1 (0.88) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL2834051 | 0.91 | ALDH1A1 (0.84) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL17052745 | 0.91 | ALDH1A1 (0.78) | ALDH1A1MAPTCYP3A4RXRARARA | |
| Beta Carotene SCHEMBL4092791 | 0.90 | ALDH1A1 (0.89) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL11417176 | 0.89 | ALDH1A1 (0.94) | ALDH1A1MAPTCYP3A4RXRARARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015143190-A1 | ENHANCED ATRA-RELATED COMPOUNDS DERIVED FROM STRUCTURE-ACTIVITY RELATIONSHIPS AND MODELING FOR INHIBITING PIN1 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2015-09-24 | — | — | WO | disclosed |
| US-7323589-B2 | Intermediates for use in retinoid synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2008-01-29 | — | — | US | disclosed |
| US-7148372-B2 | Intermediates for use in retinoid synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2006-12-12 | — | — | US | disclosed |
| US-20060135808-A1 | Novel intermediates for use in retinoid synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2006-06-22 | — | — | US | disclosed |
| US-20060106245-A1 | 1,1-bis(alkoxycarbonyl)-omega-tert-amino branched chain alkenes or conjugated polyenes; especially for the synthesis of retinoic acid, vitamin A (retinol), retinal, retinonitrile and etretinate | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2006-05-18 | — | — | US | disclosed |
| US-7009069-B2 | Intermediates for use in retinoid synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2006-03-07 | — | — | US | disclosed |
| US-20040132796-A1 | Novel intermediates for use in retinoid synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132796-A1 | Novel intermediates for use in retinoid synthesis | RXRB, RXRG, RXRA | ALDH1A1 471/4885MAPT 4866/4885CYP3A4 1323/4885 |
| US-20060106245-A1 | 1,1-bis(alkoxycarbonyl)-omega-tert-amino branched chain alkenes or conjugated polyenes; especially for the synthesis of retinoic acid, vitamin A (retinol), retinal, retinonitrile and etretinate | RBP1, ALDH1A2, RBP4 | ALDH1A1 102/4885MAPT 3916/4885CYP3A4 1941/4885 |
| US-20060135808-A1 | Novel intermediates for use in retinoid synthesis | RXRG, RXRB, RXRA | ALDH1A1 526/4885MAPT 4777/4885CYP3A4 861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.